Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOTE: Vadadustat for Anemia in Hemodialysis Patients
NCT07565701Phase 3Not yet recruiting
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of vadadustat in anemia. Primary endpoint: Proportion of patients starting three times per week vadadustat (TIW-V) who remain on TIW-V at 20 weeks. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
vadadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07565701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07565701.